Metoprolol

CHEMBL13 Phase 4 승인됨 Small molecule
Half-Life
3-7 hours
Bioavailability
Protein Binding
Molecular Weight
267.4 g/mol
LogP
1.9
Phase
4

This beta-blocker slows the heart rate and reduces the heart's workload by blocking the effects of adrenaline. It is prescribed for conditions such as high blood pressure, irregular heart rhythms, and heart failure.

분자량

267.3640 g/mol

LogP

1.90

TPSA

50.70 Ų

리핀스키 5의 법칙

통과

치료 영역

약물 분류

작용 기전

Selective beta-1 adrenergic receptor blocker.

Pharmacokinetics (PK)

Half-Life 3-7 hours

Pharmacodynamics (PD)

기전

Selective beta-1 adrenergic receptor blocker.

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COCCc1ccc(OCC(O)CNC(C)C)cc1

InChI

InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3

Molecular Formula

C15H25NO3

HBD / HBA

2 / 4

회전 가능 결합

9

무거운 원자

19

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This beta-blocker slows the heart rate and reduces the heart's workload by blocking the effects of adrenaline. It is prescribed for conditions such as high blood pressure, irregular heart rhythms, and heart failure.

Selective beta-1 adrenergic receptor blocker.

Key pharmacokinetic parameters for Metoprolol: Half-life: 3-7 hours.

Yes, Metoprolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL13. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4171. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.